BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Clinical Trials

Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

Key Points GBM AGILE pivotal study of paxalisib is recruiting ahead of expectations, with almost 25 sites now open to the paxalisib arm. Paxalisib phas...

July 01, 2021 | News

RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Preclinical Study

Opaganib's unique, orally-administered, host-targeted, dual antiviral and anti-inflammatory approach to combatting COVID-19 is also expected to maintain ef...

June 29, 2021 | News

Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia

On June 21, local time, phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured by Shen...

June 23, 2021 | News

BIO to Hold First-Ever Clinical Trial Diversity Summit

The Biotechnology Innovation Organization (BIO) will hold its first-ever BIO Clinical Trial Diversity Summit June 24-25, 2021 to focus on th...

June 22, 2021 | News

With Serum Institute as a partner, Novavax is poised to launch in India.

The Novavax trials conducted on 29,960 people in the US and Mexico have delivered results that equal the Pfizer NSE -1.09 % and Moderna jabs and do better ...

June 16, 2021 | News

Medidata to Offer Secure Platform for Decentralization of Clinical Trials

The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...

June 16, 2021 | News

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy

93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...

June 15, 2021 | News

China Pharma to Launch Highly Purified NMN+PQQ Product

NMN is a natural compound found in the human body and is constantly being metabolized. It is also found in trace amounts in certain foods. NMN serves as a ...

June 10, 2021 | News

Australian researchers lead world in successful trial of new cancer treatment

Relatlimab is the first immunotherapy treatment to target LAG-3, a protein in immune cells which reinvigorates and enhances the tumour fighting r...

June 07, 2021 | News

Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™

ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will be held virtually due to COVID-19. Some ...

June 07, 2021 | News

Vela Diagnostics Collaboration with the NCCS to Refine Novel Cancer Therapy

Being able to predict an individual's response will help clinicians determine if EGFR-TKIs are a suitable therapeutic option for the patient. The partnersh...

June 04, 2021 | News

21% were not aware Australian data is accepted by the FDA and other major regulatory authorities

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results o...

June 04, 2021 | Analysis

Akoya launches Advanced Biopharma Solutions

Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced the launch of Advanced Biopharma Solutions (ABS) as a premium serv...

June 03, 2021 | News

BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® Biosimilar

First clinical trial from BioFactura’s pipeline of high-value biosimilar and biodefense drugs BFI-751: Biosimilar designed to treat people with Cr...

June 01, 2021 | News

Stay Connected